We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Pheochromocytoma
MedXY News
EnglishTag

Pheochromocytoma

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Octreotide in the Management of Catecholamine-Secreting Pheochromocytomas and Paragangliomas: A Promising Adjunctive Therapy
Diabetes & Endocrinologycatecholaminessomatostatin receptor therapy

Octreotide in the Management of Catecholamine-Secreting Pheochromocytomas and Paragangliomas: A Promising Adjunctive Therapy

By MedXY|Aug 22, 2026

Octreotide shows potential as an effective adjunctive therapy in catecholamine-secreting pheochromocytomas and paragangliomas, improving biochemical, hemodynamic, and metabolic parameters and supporting perioperative management.

Safety of Biopsy in Pheochromocytoma and Paraganglioma: What a Global Study Found
newsbiopsy safety
catecholamine complications

Safety of Biopsy in Pheochromocytoma and Paraganglioma: What a Global Study Found

By MedXY|May 15, 2026

This international study found that biopsy of pheochromocytoma and paraganglioma had low mortality and low serious complication rates, suggesting biopsy may be reasonable in carefully selected patients with expert management.

Most Bilateral Adrenal Lesions Are Benign and Concordant, but Asynchronous Presentation Signals Higher Malignancy Risk
Diabetes & Endocrinologyadrenal incidentalomaadrenal malignancy

Most Bilateral Adrenal Lesions Are Benign and Concordant, but Asynchronous Presentation Signals Higher Malignancy Risk

By MedXY|May 13, 2026

A large retrospective cohort shows that bilateral adrenal masses are usually benign and concordant, but asynchronous or discordant lesions identify a clinically important subgroup enriched for malignancy and pheochromocytoma.

Preemptive Magnesium Sulfate Infusion Significantly Stabilizes Hemodynamics During Pheochromocytoma Resection
AnesthesiologyAnesthesiahemodynamic instability

Preemptive Magnesium Sulfate Infusion Significantly Stabilizes Hemodynamics During Pheochromocytoma Resection

By MedXY|Jan 19, 2026

A randomized, double-blind trial confirms that preemptive magnesium sulfate reduces intraoperative hemodynamic instability by nearly 50% in patients undergoing pheochromocytoma and paraganglioma resection, providing a safe and effective adj

Targeting Tumor Hypoxia Pathways: Belzutifan’s Promise in Advanced Paraganglioma and Pheochromocytoma Treatment
Diabetes & EndocrinologyBelzutifanParaganglioma

Targeting Tumor Hypoxia Pathways: Belzutifan’s Promise in Advanced Paraganglioma and Pheochromocytoma Treatment

By MedXY|Oct 24, 2025

This article reviews a phase 2 trial of belzutifan, a HIF-2α inhibitor, demonstrating durable antitumor activity and manageable safety in advanced pheochromocytoma and paraganglioma, highlighting its potential as a targeted therapy.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities